Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Arthritis and Rheumatism
|
October 19, 2000
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups
A W Morgan, B Griffiths, F Ponchel, et al.
Clinical Nuclear Medicine
|
January 1, 1990
Nuclear scintigraphy in the evaluation of renal colic
R K Brown, D K Bahn, B L Walters, et al.
Annals of the Rheumatic Diseases
|
April 1, 2008
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
C Potter, K L Hyrich, A Tracey, et al.
Clinical and Experimental Immunology
|
September 5, 2012
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients
L R Coulthard, J Geiler, R J Mathews, et al.
Annals of the Rheumatic Diseases
|
July 17, 2009
A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis
D Plant, A Barton, W Thomson, et al.
European Journal of Endocrinology
|
February 3, 2022
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial
R A Ajjan, E M A Hensor, F Del Galdo, et al.
Annals of the Rheumatic Diseases
|
August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
J L Nam, E Villeneuve, E M A Hensor, et al.
Rheumatology (Oxford, England)
|
March 22, 2003
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study
A W Morgan, V H Keyte, S J Babbage, et al.
Annals of the Rheumatic Diseases
|
August 16, 2013
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
A Serrano, A Márquez, S L Mackie, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Arthritis and Rheumatism
|
October 19, 2000
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups
A W Morgan, B Griffiths, F Ponchel, et al.
Clinical Nuclear Medicine
|
January 1, 1990
Nuclear scintigraphy in the evaluation of renal colic
R K Brown, D K Bahn, B L Walters, et al.
Annals of the Rheumatic Diseases
|
April 1, 2008
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
C Potter, K L Hyrich, A Tracey, et al.
Clinical and Experimental Immunology
|
September 5, 2012
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients
L R Coulthard, J Geiler, R J Mathews, et al.
Annals of the Rheumatic Diseases
|
July 17, 2009
A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis
D Plant, A Barton, W Thomson, et al.
European Journal of Endocrinology
|
February 3, 2022
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial
R A Ajjan, E M A Hensor, F Del Galdo, et al.
Annals of the Rheumatic Diseases
|
August 6, 2013
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
J L Nam, E Villeneuve, E M A Hensor, et al.
Rheumatology (Oxford, England)
|
March 22, 2003
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study
A W Morgan, V H Keyte, S J Babbage, et al.
Annals of the Rheumatic Diseases
|
August 16, 2013
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
A Serrano, A Márquez, S L Mackie, et al.
Page
of 3